Sinopharm Group Co(HK:1099)
HK$16.67-0.07 (-0.42%)
HK:1099
Sinopharm Group Co financials statements
HK$16.67
At close:-0.07 (-0.42%)
Want to see HK:1099 full AI Analyst Report?
Sinopharm Group Co (1099) Financial Statements
11 Followers
Sinopharm Group Co Financial Overview
Sinopharm Group Co's market cap is currently ¥52.02B. The company's EPS TTM is ¥2.25; its P/E ratio is 6.30; and it has a dividend yield of 4.74%. Sinopharm Group Co is estimated to report earnings on March 19, 2027, and the estimated EPS forecast is ¥1.37. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 575.17B | ¥ 584.51B | ¥ 596.57B | ¥ 552.15B | ¥ 521.05B |
| Gross Profit | ¥ 41.67B | ¥ 44.26B | ¥ 48.51B | ¥ 47.43B | ¥ 44.05B |
| Operating Income | ¥ 16.04B | ¥ 16.19B | ¥ 20.21B | ¥ 20.60B | ¥ 19.71B |
| EBITDA | ¥ 21.52B | ¥ 22.56B | ¥ 26.90B | ¥ 26.25B | ¥ 24.68B |
| Net Income | ¥ 7.16B | ¥ 7.05B | ¥ 9.05B | ¥ 8.53B | ¥ 7.76B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 61.59B | ¥ 54.31B | ¥ 63.81B | ¥ 55.22B | ¥ 43.54B |
| Total Assets | ¥ 390.53B | ¥ 392.83B | ¥ 383.39B | ¥ 364.78B | ¥ 335.41B |
| Total Debt | ¥ 108.63B | ¥ 76.39B | ¥ 73.78B | ¥ 69.59B | ¥ 68.37B |
| Net Debt | ¥ 47.04B | ¥ 22.07B | ¥ 9.97B | ¥ 14.37B | ¥ 24.84B |
| Total Liabilities | ¥ 256.31B | ¥ 266.14B | ¥ 263.08B | ¥ 254.71B | ¥ 235.76B |
| Stockholders' Equity | ¥ 83.99B | ¥ 78.88B | ¥ 74.58B | ¥ 68.07B | ¥ 61.89B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 12.52B | ¥ 9.58B | ¥ 14.84B | ¥ 18.55B | ¥ 7.05B |
| Operating Cash Flow | ¥ 14.14B | ¥ 11.55B | ¥ 17.17B | ¥ 20.96B | ¥ 9.31B |
| Investing Cash Flow | ¥ -963.89M | ¥ -3.75B | ¥ -944.53M | ¥ -3.59B | ¥ -1.27B |
| Financing Cash Flow | ¥ -18.69B | ¥ -17.29B | ¥ -7.64B | ¥ -5.69B | ¥ -14.69B |
Currency in CNY
